LeMaitre Vascular 관리

관리 기준 확인 3/4

LeMaitre Vascular CEO는 George LeMaitre, Jun1992 에 임명되었습니다 의 임기는 32.42 년입니다. 총 연간 보상은 $ 2.22M, 26.7% 로 구성됩니다. 26.7% 급여 및 73.3% 보너스(회사 주식 및 옵션 포함). 는 € 190.26M 가치에 해당하는 회사 주식의 8.32% 직접 소유합니다. 190.26M. 경영진과 이사회의 평균 재임 기간은 각각 14.6 년과 19 년입니다.

주요 정보

George LeMaitre

최고 경영자

US$2.2m

총 보상

CEO 급여 비율	26.7%
CEO 임기	32.4yrs
CEO 소유권	8.3%
경영진 평균 재임 기간	14.6yrs
이사회 평균 재임 기간	19yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

George LeMaitre 의 보수는 LeMaitre Vascular 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Sep 30 2024	n/a	n/a	US$41m
Jun 30 2024	n/a	n/a	US$38m
Mar 31 2024	n/a	n/a	US$34m
Dec 31 2023	US$2m	US$593k	US$30m
Sep 30 2023	n/a	n/a	US$27m
Jun 30 2023	n/a	n/a	US$25m
Mar 31 2023	n/a	n/a	US$21m
Dec 31 2022	US$2m	US$568k	US$21m
Sep 30 2022	n/a	n/a	US$21m
Jun 30 2022	n/a	n/a	US$22m
Mar 31 2022	n/a	n/a	US$27m
Dec 31 2021	US$2m	US$473k	US$27m
Sep 30 2021	n/a	n/a	US$28m
Jun 30 2021	n/a	n/a	US$29m
Mar 31 2021	n/a	n/a	US$24m
Dec 31 2020	US$1m	US$311k	US$21m
Sep 30 2020	n/a	n/a	US$19m
Jun 30 2020	n/a	n/a	US$16m
Mar 31 2020	n/a	n/a	US$18m
Dec 31 2019	US$1m	US$438k	US$18m
Sep 30 2019	n/a	n/a	US$19m
Jun 30 2019	n/a	n/a	US$18m
Mar 31 2019	n/a	n/a	US$23m
Dec 31 2018	US$1m	US$438k	US$23m
Sep 30 2018	n/a	n/a	US$21m
Jun 30 2018	n/a	n/a	US$22m
Mar 31 2018	n/a	n/a	US$18m
Dec 31 2017	US$889k	US$162k	US$17m

보상 대 시장: George 의 총 보상 ($USD 2.22M )은 German 시장( $USD 1.63M ).

보상과 수익: George 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

George LeMaitre (59 yo)

32.4yrs

테뉴어

US$2,220,797

보상

Mr. George W. LeMaitre has been Chief Executive Officer of Lemaitre Vascular, Inc. since June 1992 and has been its Chairman since 2004. Mr. LeMaitre served as the President of Lemaitre Vascular from June...

리더십 팀

이름	위치	테뉴어	보상	소유권
George LeMaitre	Chairman & CEO	32.4yrs	US$2.22m	8.32% € 190.3m
David Roberts	President & Director	17.3yrs	US$1.13m	0.063% € 1.4m
Joseph Pellegrino	CFO, Secretary & Director	17.3yrs	US$1.07m	0.039% € 895.6k
Trent Kamke	Senior Vice President of Operations	19.8yrs	US$670.38k	0.0071% € 161.6k
George LeMaitre	Founder and Chairman of Scientific Advisory Board	41.8yrs	US$138.40k	데이터 없음
Kimberly Cieslak	Vice President of Marketing	21.8yrs	데이터 없음	데이터 없음
Daniel Mumford	Senior Director of Human Resources	4.8yrs	데이터 없음	데이터 없음
Jonathan Ngau	Senior Vice President of Information Technology	less than a year	데이터 없음	데이터 없음
Maik Helmers	Senior Vice President of Sales – Central Europe	less than a year	데이터 없음	데이터 없음
Ryan Connelly	Senior Vice President of Advanced Manufacturing Engineering	1.8yrs	데이터 없음	데이터 없음
Andrew Hodgkinson	Senior Vice President of Clinical	11.8yrs	데이터 없음	데이터 없음
Stephane Maier	Senior Vice President of EMEA Operations	4.1yrs	데이터 없음	데이터 없음

14.6yrs

평균 재임 기간

50.5yo

평균 연령

경험이 풍부한 관리: LHU 의 관리팀은 노련하고 경험 (평균 재직 기간 14.6 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
George LeMaitre	Chairman & CEO	32.4yrs	US$2.22m	8.32% € 190.3m
David Roberts	President & Director	23.5yrs	US$1.13m	0.063% € 1.4m
Joseph Pellegrino	CFO, Secretary & Director	8.1yrs	US$1.07m	0.039% € 895.6k
George LeMaitre	Founder and Chairman of Scientific Advisory Board	no data	US$138.40k	데이터 없음
Lawrence Jasinski	Independent Director	21.8yrs	US$153.50k	0.019% € 427.9k
Thomas Naslund	Member of Scientific Advisory Board	no data	데이터 없음	데이터 없음
Steven Kagan	Member of Scientific Advisory Board	no data	데이터 없음	데이터 없음
Herbert Dardik	Member of Scientific Advisory Board	no data	데이터 없음	데이터 없음
Alan Dardik	Member of Scientific Advisory Board	no data	데이터 없음	데이터 없음
William Jordan	Member of Scientific Advisory Board	no data	데이터 없음	데이터 없음
John O'Connor	Independent Director	16.2yrs	US$163.00k	0.21% € 4.9m
Bridget Ross	Independent Director	4.6yrs	US$144.50k	0.0052% € 119.8k

19.0yrs

평균 재임 기간

60yo

평균 연령

경험이 풍부한 이사회: LHU 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 19 년).

LeMaitre Vascular 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

President & Director recently sold €353k worth of stock

LeMaitre Vascular, Inc., Annual General Meeting, Jun 03, 2024

Chairman & CEO recently sold €6.4m worth of stock

Chairman & CEO recently sold €2.6m worth of stock

Chairman & CEO recently sold €411k worth of stock

President & Director recently sold €505k worth of stock

Recent updates

Third quarter dividend of US$0.16 announced

Lemaitre Vascular, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ending December 31, 2024

Third quarter 2024 earnings released: EPS: US$0.50 (vs US$0.34 in 3Q 2023)

LeMaitre Vascular, Inc. to Report Q3, 2024 Results on Oct 31, 2024

Second quarter dividend of US$0.16 announced

LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on August 29, 2024

Second quarter 2024 earnings released: EPS: US$0.53 (vs US$0.36 in 2Q 2023)

LeMaitre Vascular, Inc. to Report Q2, 2024 Results on Aug 01, 2024

First quarter dividend of US$0.16 announced

President & Director recently sold €353k worth of stock

First quarter 2024 earnings released: EPS: US$0.44 (vs US$0.27 in 1Q 2023)

LeMaitre Vascular, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2024

LeMaitre Vascular, Inc. to Report Q1, 2024 Results on May 02, 2024

LeMaitre Vascular, Inc., Annual General Meeting, Jun 03, 2024

Chairman & CEO recently sold €6.4m worth of stock

Upcoming dividend of US$0.16 per share

Fourth quarter dividend of US$0.16 announced

LeMaitre Vascular, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024

Full year 2023 earnings released: EPS: US$1.36 (vs US$0.94 in FY 2022)

LeMaitre Vascular, Inc. (NasdaqGM:LMAT) announces an Equity Buyback for $50 million worth of its shares.

LeMaitre Vascular, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Chairman & CEO recently sold €2.6m worth of stock

Upcoming dividend of US$0.14 per share at 1.1% yield

Third quarter 2023 earnings released: EPS: US$0.34 (vs US$0.25 in 3Q 2022)

LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on November 30, 2023

Now 20% undervalued after recent price drop

LeMaitre Vascular, Inc. to Report Q3, 2023 Results on Nov 01, 2023

Investor sentiment deteriorates as stock falls 19%

Upcoming dividend of US$0.14 per share at 1.0% yield

LeMaitre Vascular, Inc. Provides Earnings Guidance for the Third Quarter Ending September 30, 2023, Fourth Quarter and Full Year Ending December 31, 2023

Second quarter 2023 earnings released: EPS: US$0.36 (vs US$0.16 in 2Q 2022)

LeMaitre Vascular, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Chairman & CEO recently sold €411k worth of stock

Upcoming dividend of US$0.14 per share at 0.8% yield

President & Director recently sold €505k worth of stock

LeMaitre Vascular, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2023

First quarter 2023 earnings released: EPS: US$0.27 (vs US$0.28 in 1Q 2022)

Insufficient new directors

Senior Vice President of Operations recently sold €308k worth of stock

Full year 2022 earnings released: EPS: US$0.94 (vs US$1.27 in FY 2021)

LeMaitre Vascular, Inc. to Report Q4, 2022 Results on Feb 23, 2023

Upcoming dividend of US$0.13 per share

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: EPS: US$0.25 (vs US$0.30 in 3Q 2021)

LeMaitre Vascular, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022

LeMaitre Vascular, Inc. to Report Q3, 2022 Results on Oct 27, 2022

Lemaitre Vascular, Inc. Appoints Martha Shadan as Director

Upcoming dividend of US$0.13 per share

CFO, Treasurer recently sold €146k worth of stock

CFO, Treasurer recently sold €146k worth of stock

Second quarter 2022 earnings released: EPS: US$0.16 (vs US$0.40 in 2Q 2021)

LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on September 8, 2022

LeMaitre Vascular, Inc. to Report Q2, 2022 Results on Jul 28, 2022

Now 21% undervalued

First quarter 2022 earnings released: EPS: US$0.28 (vs US$0.29 in 1Q 2021)

LeMaitre Vascular, Inc. to Report Q1, 2022 Results on Apr 28, 2022

LeMaitre Vascular, Inc., Annual General Meeting, Jun 01, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

LeMaitre Vascular, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2022

LeMaitre Vascular, Inc. to Report Q4, 2021 Results on Feb 24, 2022

Now 22% undervalued after recent price drop

Now 21% undervalued after recent price drop

Upcoming dividend of US$0.11 per share

Third quarter 2021 earnings released: EPS US$0.30 (vs US$0.37 in 3Q 2020)

Upcoming dividend of US$0.11 per share

Second quarter 2021 earnings released: EPS US$0.40 (vs US$0.17 in 2Q 2020)

LeMaitre Vascular, Inc. has completed a Follow-on Equity Offering in the amount of $54.5 million.

LeMaitre Vascular, Inc.(NasdaqGM:LMAT) dropped from Russell 3000E Value Index

Upcoming dividend of US$0.11 per share